Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 84 M101 M88 M91 M103 M 383 M Research & development ————— — Operating income 455 M648 M580 M617 M863 M 2.71 B Non-Operating Income, Total 2 M6 M3 M7 M-3 M 13 M Interest expense, net of interest capitalized 37 M36 M41 M41 M39 M 157 M Non-Operating Income, excl. Interest Expenses -37 M-36 M-41 M-42 M-42 M -161 M Unusual income/expense 2 M6 M3 M8 M0 17 M Pretax income 437 M635 M565 M602 M844 M 2.65 B Equity in earnings 4 M2 M1 M—6 M — Taxes 86 M143 M105 M107 M168 M 523 M Non-controlling/minority interest 39 M106 M107 M91 M61 M 365 M After tax other income/expense ————— — Net income before discontinued operations 351 M492 M460 M495 M676 M 2.12 B Discontinued operations ————— — Net income 351 M492 M460 M495 M676 M 2.12 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 312 M386 M353 M404 M615 M 1.76 B Basic earnings per share (Basic EPS) 1.852.372.192.573.99 11.12 Diluted earnings per share (Diluted EPS) 1.852.372.192.563.98 11.1 Average basic shares outstanding 168.6 M162.9 M161 M162.1 M154.2 M — Diluted shares outstanding 168.8 M163.1 M161.2 M162.2 M154.5 M — EBITDA 612 M777 M702 M751 M1.06 B 3.29 B EBIT 343 M545 M485 M523 M836 M 2.39 B Cost of revenue 1.09 B1.14 B1.03 B1.11 B1.24 B 4.51 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 221 M232 M217 M228 M228 M 905 M